Fosun Pharmaceu...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Concert Pharmaceuticals
Fosun Pharmaceutical bought Concert Pharmaceuticals
1/19/23 at 17:11
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.
Concert Pharmaceuticals
Review
Source:
ir.concertpharma.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
RBC reports for 3 months of 2025 by RAS
5/16/25
RBCM
Shareholders of KuibyshevAzot approved dividends for 2024
5/16/25
KAZT
Shareholders of RPA Nauka approved dividends for 2024
5/16/25
NAUK
Rosseti Tomsk reported for 3 months of 2025 by IFRS
5/16/25
TORS
Cherkizovo reports for the 3 months of 2025 by IFRS
5/16/25
GCHE
Levenguc reported for 3 months of 2025 by RAS
5/16/25
LVHK
Bank Saint-Petersburg reported for 3 months of 2025 by IFRS
5/16/25
BSPB
Shareholders of Territorial Generating Company β 14 approved dividends for 2024
5/16/25
TGKN
Board of Directors of Novorossiysk Bakery Products Plant recommended that dividends be paid for 2024
5/16/25
NKHP
Board of Directors of Diod recommended that dividends be paid for 3 months 2025
5/16/25
DIOD
«
Previous
2
3
4
5
6
7
8
9
10
11
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
ir.concertpharma.com ir.concertpharma.com ir.concertpharma.com
English (US) 